Literature DB >> 23523779

Potency optimization of Huwentoxin-IV on hNav1.7: a neurotoxin TTX-S sodium-channel antagonist from the venom of the Chinese bird-eating spider Selenocosmia huwena.

Jefferson D Revell1, Per-Eric Lund, John E Linley, Jacky Metcalfe, Nicole Burmeister, Sudharsan Sridharan, Clare Jones, Lutz Jermutus, Maria A Bednarek.   

Abstract

The spider venom peptide Huwentoxin-IV (HwTx-IV) 1 is a potent antagonist of hNav1.7 (IC50 determined herein as 17 ± 2 nM). Nav1.7 is a voltage-gated sodium channel involved in the generation and conduction of neuropathic and nociceptive pain signals. We prepared a number of HwTx-IV analogs as part of a structure-function study into Nav1.7 antagonism. The inhibitory potency of these analogs was determined by automated electrophysiology and is reported herein. In particular, the native residues Glu(1), Glu(4), Phe(6) and Tyr(33) were revealed as important activity modulators and several peptides bearing mutations in these positions showed significantly increased potency on hNav1.7 while maintaining the original selectivity profile of the wild-type peptide 1 on hNav1.5. Peptide 47 (Gly(1), Gly(4), Trp(33)-HwTx) demonstrated the largest potency increase on hNav1.7 (IC50 0.4 ± 0.1 nM).
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23523779     DOI: 10.1016/j.peptides.2013.03.011

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  31 in total

1.  Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNav1.7.

Authors:  Robert A Neff; Mack Flinspach; Alan Gibbs; Amy Y Shih; Natali A Minassian; Yi Liu; Ross Fellows; Ondrej Libiger; Stephanie Young; Michael W Pennington; Michael J Hunter; Alan D Wickenden
Journal:  J Biol Chem       Date:  2019-12-23       Impact factor: 5.157

Review 2.  Trends in peptide drug discovery.

Authors:  Markus Muttenthaler; Glenn F King; David J Adams; Paul F Alewood
Journal:  Nat Rev Drug Discov       Date:  2021-02-03       Impact factor: 84.694

Review 3.  Sodium channels and pain: from toxins to therapies.

Authors:  Fernanda C Cardoso; Richard J Lewis
Journal:  Br J Pharmacol       Date:  2017-09-02       Impact factor: 8.739

4.  Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7.

Authors:  Akello J Agwa; Poanna Tran; Alexander Mueller; Hue N T Tran; Jennifer R Deuis; Mathilde R Israel; Kirsten L McMahon; David J Craik; Irina Vetter; Christina I Schroeder
Journal:  J Biol Chem       Date:  2020-03-05       Impact factor: 5.157

Review 5.  Anticancer, antimicrobial, and analgesic activities of spider venoms.

Authors:  Hassan M Akef
Journal:  Toxicol Res (Camb)       Date:  2018-03-08       Impact factor: 3.524

6.  Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach.

Authors:  Julie K Klint; Jennifer J Smith; Irina Vetter; Darshani B Rupasinghe; Sing Yan Er; Sebastian Senff; Volker Herzig; Mehdi Mobli; Richard J Lewis; Frank Bosmans; Glenn F King
Journal:  Br J Pharmacol       Date:  2015-03-04       Impact factor: 8.739

Review 7.  From foe to friend: using animal toxins to investigate ion channel function.

Authors:  Jeet Kalia; Mirela Milescu; Juan Salvatierra; Jordan Wagner; Julie K Klint; Glenn F King; Baldomero M Olivera; Frank Bosmans
Journal:  J Mol Biol       Date:  2014-08-01       Impact factor: 5.469

8.  Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain.

Authors:  Anatoly Shcherbatko; Andrea Rossi; Davide Foletti; Guoyun Zhu; Oren Bogin; Meritxell Galindo Casas; Mathias Rickert; Adela Hasa-Moreno; Victor Bartsevich; Andreas Crameri; Alexander R Steiner; Robert Henningsen; Avinash Gill; Jaume Pons; David L Shelton; Arvind Rajpal; Pavel Strop
Journal:  J Biol Chem       Date:  2016-04-22       Impact factor: 5.157

9.  µ-TRTX-Ca1a: a novel neurotoxin from Cyriopagopus albostriatus with analgesic effects.

Authors:  Yun-Xiao Zhang; De-Zheng Peng; Qing-Feng Zhang; Biao Huang; Qiu-Chu Yang; Dong-Fang Tang; Min-Zhi Chen; Ming-Qiang Rong; Zhong-Hua Liu
Journal:  Acta Pharmacol Sin       Date:  2018-10-31       Impact factor: 6.150

10.  Structural Basis for High-Affinity Trapping of the NaV1.7 Channel in Its Resting State by Tarantula Toxin.

Authors:  Goragot Wisedchaisri; Lige Tonggu; Tamer M Gamal El-Din; Eedann McCord; Ning Zheng; William A Catterall
Journal:  Mol Cell       Date:  2020-11-23       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.